The Latest Developments In Oncology’s Research Boom

The long list of new treatments reflects the advent of cancer immunotherapy as well as continued progress in matching treatment to genetics. New drugs for lung, breast, skin and blood cancers have made gains over standard of care, while other additions have expanded options for patients.

INCLUDED IN THIS TRENDLINE

  • Merck and Pfizer demonstrate how they tap sites for cancer trials
  • Impact of coronavirus on cancer research
  • Latest trends and challenges in cancer immunotherapy

Request Free!